Zobrazeno 1 - 10
of 64
pro vyhledávání: '"F Bianic"'
Autor:
S. Popat, S. Stergiopoulos, S. King, M. Curtis, A. Dillon, R. Akehurst, D. Lee, F. Guelfucci, A. Ngami, F. Bianic, Y. Li, S. Ali, V. Miller
Publikováno v:
Annals of Oncology. 33:S1012-S1013
EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon?
Publikováno v:
Value in Health. 25:S226
Publikováno v:
Value in Health. 25:S139
Publikováno v:
Value in Health. 25:S270
Publikováno v:
Value in Health. 25:S337
Autor:
S Stergiopoulos, S King, M Curtis, SA Dillon, R Akehurst, D Lee, F Guelfucci, A Ngami, F Bianic, Y Li, X Ma, S Ali, VA Miller, S Popat
Publikováno v:
Value in Health. 25:S42
Publikováno v:
Value in Health. 25:S470
Publikováno v:
Value in Health
Objectives: Following the Covid-19 pandemic, the World Health Organization (WHO) issued target product profiles (TPP) for Covid-19 vaccines Assuming SARS-CoV-2 would become recurrent and seasonal, the aim of this study was to conduct an early assessm
Publikováno v:
Infectious Diseases Now. 51:S23-S24
Introduction Les epidemies de grippe sont responsables chaque annee d’un lourd fardeau economique et de sante publique, en particulier dans la population âgee de 65 ans et plus (seniors). La necessite d’ameliorer les vaccins dans cette tranche d
To indirectly compare the efficacy of telaprevir (TVR) and boceprevir (BOC) combined with peginterferon/ribavirin α-2a/2b (PR) in achieving sustained viral response (SVR) in treatment-naïve and treatment-experienced patients with genotype 1 chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57cba2f311ba52487f9c8400d13e484